{"transactions":[{"id":4637370,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":1009,"kind":"person","name":"Borgeson Blake","position":1,"cik":"0001856094","reported_name":"Borgeson Blake","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-10-07T22:08:44.000Z","date":"2026-10-06","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":4.84,"value":242000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $4.80 to $5.00. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":6108287,"source":{"system":"sec-edgar","filing":"0001601830-26-000120","document":"wk-form4_1791410921.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856094/000160183026000120/wk-form4_1791410921.xml","form_type":"4"}},{"id":4637369,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-10-07T22:08:23.000Z","date":"2026-10-06","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":2.22,"value":55500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One forty-eighth (1/48th) of the shares subject to the award shall vest one month after March 16, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date. Date exercisable varies by tranche."}],"balance_after":500000,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-19","underlying":"Class A Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001601830-26-000119","document":"wk-form4_1791410900.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183026000119/wk-form4_1791410900.xml","form_type":"4"}},{"id":4637368,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-10-07T22:08:23.000Z","date":"2026-10-06","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":5,"value":125000.0,"ownership":{"direct":true},"balance_after":162156,"source":{"system":"sec-edgar","filing":"0001601830-26-000119","document":"wk-form4_1791410900.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183026000119/wk-form4_1791410900.xml","form_type":"4"}},{"id":4637367,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-10-07T22:08:23.000Z","date":"2026-10-06","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":2.22,"value":55500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2025."}],"balance_after":187156,"source":{"system":"sec-edgar","filing":"0001601830-26-000119","document":"wk-form4_1791410900.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183026000119/wk-form4_1791410900.xml","form_type":"4"}},{"id":4628848,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":32942,"kind":"person","name":"Dar Zavain","position":1,"cik":"0001852075","reported_name":"Dar Zavain","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-10-02T22:17:44.000Z","date":"2026-10-01","kind":"grant","planned":false,"acquired":true,"shares":4607,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":245371,"source":{"system":"sec-edgar","filing":"0001601830-26-000116","document":"wk-form4_1790979462.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852075/000160183026000116/wk-form4_1790979462.xml","form_type":"4"}},{"id":4628851,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":10863,"kind":"person","name":"Li Dean Y","position":1,"cik":"0001837016","reported_name":"Li Dean Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-10-02T22:17:05.000Z","date":"2026-10-01","kind":"grant","planned":false,"acquired":true,"shares":3378,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":1476707,"source":{"system":"sec-edgar","filing":"0001601830-26-000115","document":"wk-form4_1790979423.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1837016/000160183026000115/wk-form4_1790979423.xml","form_type":"4"}},{"id":4619914,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-09-16T21:52:03.000Z","date":"2026-09-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":5396,"price":3.41,"value":18400.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":1071462,"source":{"system":"sec-edgar","filing":"0001601830-26-000110","document":"wk-form4_1789595520.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712276/000160183026000110/wk-form4_1789595520.xml","form_type":"4"}},{"id":4615083,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22356,"kind":"person","name":"Khan Najat","position":1,"cik":"0002020969","reported_name":"Khan Najat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Class A Common Stock","published_at":"2026-09-10T21:55:57.000Z","date":"2026-09-08","kind":"sale","planned":true,"acquired":false,"shares":22408,"price":3.5176,"value":78822.3808,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $3.485 to $3.58. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":2072890,"source":{"system":"sec-edgar","filing":"0001601830-26-000105","document":"wk-form4_1789077354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2020969/000160183026000105/wk-form4_1789077354.xml","form_type":"4"}},{"id":1185,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":1009,"kind":"person","name":"Borgeson Blake","position":1,"cik":"0001856094","reported_name":"Borgeson Blake","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-09-02T22:01:55.000Z","date":"2026-09-01","kind":"sale","planned":true,"acquired":false,"shares":30000,"price":3.34,"value":100200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2025."}],"balance_after":6158287,"source":{"system":"sec-edgar","filing":"0001601830-26-000103","document":"wk-form4_1788386512.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856094/000160183026000103/wk-form4_1788386512.xml","form_type":"4"}},{"id":683873,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22356,"kind":"person","name":"Khan Najat","position":1,"cik":"0002020969","reported_name":"Khan Najat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Class A Common Stock","published_at":"2026-08-18T21:44:34.000Z","date":"2026-08-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":80498,"price":3.16,"value":254373.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":2095298,"source":{"system":"sec-edgar","filing":"0002020969-26-000006","document":"wk-form4_1787089472.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2020969/000202096926000006/wk-form4_1787089472.xml","form_type":"4"}},{"id":683816,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22339,"kind":"person","name":"Hallett David","position":1,"cik":"0002006495","reported_name":"Hallett David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Class A Common Stock","published_at":"2026-08-18T21:44:29.000Z","date":"2026-08-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":26657,"price":3.16,"value":84236.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":1043837,"source":{"system":"sec-edgar","filing":"0002006495-26-000012","document":"wk-form4_1787089466.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2006495/000200649526000012/wk-form4_1787089466.xml","form_type":"4"}},{"id":682793,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-08-18T21:44:23.000Z","date":"2026-08-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":25018,"price":3.16,"value":79056.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":1076858,"source":{"system":"sec-edgar","filing":"0001712276-26-000009","document":"wk-form4_1787089461.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000171227626000009/wk-form4_1787089461.xml","form_type":"4"}},{"id":693930,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":1009,"kind":"person","name":"Borgeson Blake","position":1,"cik":"0001856094","reported_name":"Borgeson Blake","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-06T21:09:25.000Z","date":"2026-08-04","kind":"sale","planned":true,"acquired":false,"shares":30000,"price":3.25,"value":97500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2025."}],"balance_after":6188287,"source":{"system":"sec-edgar","filing":"0001856094-26-000014","document":"wk-form4_1786050562.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000185609426000014/wk-form4_1786050562.xml","form_type":"4"}},{"id":711674,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":1009,"kind":"person","name":"Borgeson Blake","position":1,"cik":"0001856094","reported_name":"Borgeson Blake","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-07-09T22:04:18.000Z","date":"2026-07-07","kind":"sale","planned":true,"acquired":false,"shares":40000,"price":3.9625,"value":158500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $3.95 to $4.00. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":6218287,"source":{"system":"sec-edgar","filing":"0001856094-26-000011","document":"wk-form4_1783634656.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000185609426000011/wk-form4_1783634656.xml","form_type":"4"}},{"id":718250,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":32942,"kind":"person","name":"Dar Zavain","position":1,"cik":"0001852075","reported_name":"Dar Zavain","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-07-02T21:15:51.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":5109,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":240764,"source":{"system":"sec-edgar","filing":"0001601830-26-000092","document":"wk-form4_1783026949.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852075/000160183026000092/wk-form4_1783026949.xml","form_type":"4"}},{"id":717190,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":10863,"kind":"person","name":"Li Dean Y","position":1,"cik":"0001837016","reported_name":"Li Dean Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-07-02T21:15:43.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":3747,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":1473329,"source":{"system":"sec-edgar","filing":"0001601830-26-000091","document":"wk-form4_1783026941.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183026000091/wk-form4_1783026941.xml","form_type":"4"}},{"id":730039,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":1009,"kind":"person","name":"Borgeson Blake","position":1,"cik":"0001856094","reported_name":"Borgeson Blake","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-22T20:32:41.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":88424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units automatically granted pursuant to the Issuer's Outside Director Compensation Policy. The restricted stock units will vest on the earlier of June 17,2027 or the day prior to the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":6258287,"source":{"system":"sec-edgar","filing":"0001601830-26-000088","document":"wk-form4_1782160357.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183026000088/wk-form4_1782160357.xml","form_type":"4"}},{"id":730221,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-22T20:32:34.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":88424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units automatically granted pursuant to the Issuer's Outside Director Compensation Policy. The restricted stock units will vest on the earlier of June 17,2027 or the day prior to the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":162156,"source":{"system":"sec-edgar","filing":"0001601830-26-000087","document":"wk-form4_1782160351.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274139/000160183026000087/wk-form4_1782160351.xml","form_type":"4"}},{"id":730817,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":36436,"kind":"person","name":"Michor Franziska","position":1,"cik":"0002045159","reported_name":"Michor Franziska","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-22T20:32:28.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":88424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units automatically granted pursuant to the Issuer's Outside Director Compensation Policy. The restricted stock units will vest on the earlier of June 17,2027 or the day prior to the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":215477,"source":{"system":"sec-edgar","filing":"0001601830-26-000086","document":"wk-form4_1782160342.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2045159/000160183026000086/wk-form4_1782160342.xml","form_type":"4"}},{"id":730551,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":36348,"kind":"person","name":"Sun Elaine D","position":1,"cik":"0001805339","reported_name":"Sun Elaine D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-22T20:32:19.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":88424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units automatically granted pursuant to the Issuer's Outside Director Compensation Policy. The restricted stock units will vest on the earlier of June 17,2027 or the day prior to the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":135981,"source":{"system":"sec-edgar","filing":"0001601830-26-000085","document":"wk-form4_1782160336.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805339/000160183026000085/wk-form4_1782160336.xml","form_type":"4"}},{"id":730639,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":32942,"kind":"person","name":"Dar Zavain","position":1,"cik":"0001852075","reported_name":"Dar Zavain","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-22T20:32:13.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":88424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units automatically granted pursuant to the Issuer's Outside Director Compensation Policy. The restricted stock units will vest on the earlier of June 17,2027 or the day prior to the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":235655,"source":{"system":"sec-edgar","filing":"0001601830-26-000084","document":"wk-form4_1782160331.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852075/000160183026000084/wk-form4_1782160331.xml","form_type":"4"}},{"id":730037,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":10863,"kind":"person","name":"Li Dean Y","position":1,"cik":"0001837016","reported_name":"Li Dean Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-22T20:32:08.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":88424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units automatically granted pursuant to the Issuer's Outside Director Compensation Policy. The restricted stock units will vest on the earlier of June 17,2027 or the day prior to the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 136,981 shares of Class A common stock transferred from the Dean Y. Li GRAT on May 7, 2026."}],"balance_after":1469582,"source":{"system":"sec-edgar","filing":"0001601830-26-000083","document":"wk-form4_1782160325.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183026000083/wk-form4_1782160325.xml","form_type":"4"}},{"id":730827,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":36440,"kind":"person","name":"Bumpus Namandje","position":1,"cik":"0002060594","reported_name":"Bumpus Namandje","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-22T20:32:02.000Z","date":"2026-06-18","kind":"sale","planned":true,"acquired":false,"shares":3963,"price":3.18,"value":12602.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026."}],"balance_after":127632,"source":{"system":"sec-edgar","filing":"0001601830-26-000082","document":"wk-form4_1782160319.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2060594/000160183026000082/wk-form4_1782160319.xml","form_type":"4"}},{"id":730826,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":36440,"kind":"person","name":"Bumpus Namandje","position":1,"cik":"0002060594","reported_name":"Bumpus Namandje","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-22T20:32:02.000Z","date":"2026-06-17","kind":"grant","planned":true,"acquired":true,"shares":88424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units automatically granted pursuant to the Issuer's Outside Director Compensation Policy. The restricted stock units will vest on the earlier of June 17,2027 or the day prior to the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":131595,"source":{"system":"sec-edgar","filing":"0001601830-26-000082","document":"wk-form4_1782160319.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2060594/000160183026000082/wk-form4_1782160319.xml","form_type":"4"}},{"id":733408,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-06-17T21:07:31.000Z","date":"2026-06-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":5396,"price":3.15,"value":16997.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":1101876,"source":{"system":"sec-edgar","filing":"0001712276-26-000007","document":"wk-form4_1781730449.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000171227626000007/wk-form4_1781730449.xml","form_type":"4"}},{"id":748179,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2026-06-05T21:03:03.000Z","date":"2026-06-05","kind":"exercise","planned":true,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the automatic conversion of Class B Common Stock into Class A Common Stock in connection with a sale of the shares by the Reporting Person.  Each share of Class B Common Stock is convertible into one share of Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."}],"balance_after":4263334,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001856369-26-000023","document":"wk-form4_1780693380.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000023/wk-form4_1780693380.xml","form_type":"4"}},{"id":748178,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-05T21:03:03.000Z","date":"2026-06-05","kind":"sale","planned":true,"acquired":false,"shares":40000,"price":3.62,"value":144800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":883735,"source":{"system":"sec-edgar","filing":"0001856369-26-000023","document":"wk-form4_1780693380.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000023/wk-form4_1780693380.xml","form_type":"4"}},{"id":748177,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-05T21:03:03.000Z","date":"2026-06-05","kind":"exercise","planned":true,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the automatic conversion of Class B Common Stock into Class A Common Stock in connection with a sale of the shares by the Reporting Person.  Each share of Class B Common Stock is convertible into one share of Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":923735,"source":{"system":"sec-edgar","filing":"0001856369-26-000023","document":"wk-form4_1780693380.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000023/wk-form4_1780693380.xml","form_type":"4"}},{"id":748320,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22356,"kind":"person","name":"Khan Najat","position":1,"cik":"0002020969","reported_name":"Khan Najat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Class A Common Stock","published_at":"2026-06-05T21:02:57.000Z","date":"2026-06-05","kind":"sale","planned":true,"acquired":false,"shares":23588,"price":3.5806,"value":84459.1928,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $3.56 to $3.62. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":2175796,"source":{"system":"sec-edgar","filing":"0002020969-26-000004","document":"wk-form4_1780693375.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2020969/000202096926000004/wk-form4_1780693375.xml","form_type":"4"}},{"id":749920,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":36440,"kind":"person","name":"Bumpus Namandje","position":1,"cik":"0002060594","reported_name":"Bumpus Namandje","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-04T21:04:57.000Z","date":"2026-06-03","kind":"sale","planned":true,"acquired":false,"shares":4386,"price":3.54,"value":15526.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026."}],"balance_after":43171,"source":{"system":"sec-edgar","filing":"0002060594-26-000003","document":"wk-form4_1780607095.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2060594/000206059426000003/wk-form4_1780607095.xml","form_type":"4"}},{"id":749154,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":1009,"kind":"person","name":"Borgeson Blake","position":1,"cik":"0001856094","reported_name":"Borgeson Blake","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-04T21:04:51.000Z","date":"2026-06-02","kind":"sale","planned":true,"acquired":false,"shares":30000,"price":3.68,"value":110400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2025."}],"balance_after":6169863,"source":{"system":"sec-edgar","filing":"0001856094-26-000008","document":"wk-form4_1780607089.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000185609426000008/wk-form4_1780607089.xml","form_type":"4"}},{"id":762018,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2026-05-27T20:15:15.000Z","date":"2026-05-22","kind":"exercise","planned":true,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the automatic conversion of Class B Common Stock into Class A Common Stock in connection with a sale of the shares by the Reporting Person.  Each share of Class B Common Stock is convertible into one share of Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."}],"balance_after":4303334,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001856369-26-000019","document":"wk-form4_1779912912.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000019/wk-form4_1779912912.xml","form_type":"4"}},{"id":762017,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-05-27T20:15:15.000Z","date":"2026-05-22","kind":"sale","planned":true,"acquired":false,"shares":40000,"price":3.08,"value":123200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":883735,"source":{"system":"sec-edgar","filing":"0001856369-26-000019","document":"wk-form4_1779912912.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000019/wk-form4_1779912912.xml","form_type":"4"}},{"id":762016,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-05-27T20:15:15.000Z","date":"2026-05-22","kind":"exercise","planned":true,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the automatic conversion of Class B Common Stock into Class A Common Stock in connection with a sale of the shares by the Reporting Person.  Each share of Class B Common Stock is convertible into one share of Class A Common Stock."}],"balance_after":923735,"source":{"system":"sec-edgar","filing":"0001856369-26-000019","document":"wk-form4_1779912912.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000019/wk-form4_1779912912.xml","form_type":"4"}},{"id":772504,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22339,"kind":"person","name":"Hallett David","position":1,"cik":"0002006495","reported_name":"Hallett David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Class A Common Stock","published_at":"2026-05-19T21:54:56.000Z","date":"2026-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":26657,"price":3.04,"value":81037.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":1070494,"source":{"system":"sec-edgar","filing":"0002006495-26-000010","document":"wk-form4_1779227693.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2006495/000200649526000010/wk-form4_1779227693.xml","form_type":"4"}},{"id":772565,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22356,"kind":"person","name":"Khan Najat","position":1,"cik":"0002020969","reported_name":"Khan Najat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Class A Common Stock","published_at":"2026-05-19T21:54:50.000Z","date":"2026-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":62701,"price":3.04,"value":190611.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":2199384,"source":{"system":"sec-edgar","filing":"0002020969-26-000002","document":"wk-form4_1779227687.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2020969/000202096926000002/wk-form4_1779227687.xml","form_type":"4"}},{"id":771241,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-05-19T21:54:44.000Z","date":"2026-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":25018,"price":3.04,"value":76054.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":1107272,"source":{"system":"sec-edgar","filing":"0001712276-26-000005","document":"wk-form4_1779227682.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000171227626000005/wk-form4_1779227682.xml","form_type":"4"}},{"id":772325,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-05-19T21:54:36.000Z","date":"2026-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":22821,"price":3.04,"value":69375.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":883735,"source":{"system":"sec-edgar","filing":"0001856369-26-000017","document":"wk-form4_1779227673.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000017/wk-form4_1779227673.xml","form_type":"4"}},{"id":786978,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2026-05-08T20:59:21.000Z","date":"2026-05-07","kind":"exercise","planned":true,"acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."}],"balance_after":4343334,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001856369-26-000015","document":"wk-form4_1778273958.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000015/wk-form4_1778273958.xml","form_type":"4"}},{"id":786977,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-05-08T20:59:21.000Z","date":"2026-05-07","kind":"gift","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":906556,"source":{"system":"sec-edgar","filing":"0001856369-26-000015","document":"wk-form4_1778273958.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000015/wk-form4_1778273958.xml","form_type":"4"}},{"id":786976,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-05-08T20:59:21.000Z","date":"2026-05-07","kind":"sale","planned":true,"acquired":false,"shares":40000,"price":3.37,"value":134800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":926556,"source":{"system":"sec-edgar","filing":"0001856369-26-000015","document":"wk-form4_1778273958.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000015/wk-form4_1778273958.xml","form_type":"4"}},{"id":786975,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-05-08T20:59:21.000Z","date":"2026-05-07","kind":"exercise","planned":true,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":966556,"source":{"system":"sec-edgar","filing":"0001856369-26-000015","document":"wk-form4_1778273958.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000015/wk-form4_1778273958.xml","form_type":"4"}},{"id":788240,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":1009,"kind":"person","name":"Borgeson Blake","position":1,"cik":"0001856094","reported_name":"Borgeson Blake","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-05-07T20:44:43.000Z","date":"2026-05-05","kind":"sale","planned":true,"acquired":false,"shares":30000,"price":3.52,"value":105600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2025."}],"balance_after":6199863,"source":{"system":"sec-edgar","filing":"0001856094-26-000005","document":"wk-form4_1778186681.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000185609426000005/wk-form4_1778186681.xml","form_type":"4"}},{"id":801037,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2026-04-24T20:23:14.000Z","date":"2026-04-22","kind":"exercise","planned":true,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."}],"balance_after":4403334,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001856369-26-000013","document":"wk-form4_1777062192.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000013/wk-form4_1777062192.xml","form_type":"4"}},{"id":801036,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-24T20:23:14.000Z","date":"2026-04-22","kind":"sale","planned":true,"acquired":false,"shares":40000,"price":3.61,"value":144400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":906556,"source":{"system":"sec-edgar","filing":"0001856369-26-000013","document":"wk-form4_1777062192.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000013/wk-form4_1777062192.xml","form_type":"4"}},{"id":801035,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-24T20:23:14.000Z","date":"2026-04-22","kind":"exercise","planned":true,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":946556,"source":{"system":"sec-edgar","filing":"0001856369-26-000013","document":"wk-form4_1777062192.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000013/wk-form4_1777062192.xml","form_type":"4"}},{"id":812293,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-04-08T20:58:31.000Z","date":"2026-04-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":48028,"price":3.11,"value":149367.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":1132290,"source":{"system":"sec-edgar","filing":"0001712276-26-000003","document":"wk-form4_1775681908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000171227626000003/wk-form4_1775681908.xml","form_type":"4"}},{"id":812635,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2026-04-08T20:58:25.000Z","date":"2026-04-07","kind":"exercise","planned":true,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."}],"balance_after":4443334,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001856369-26-000008","document":"wk-form4_1775681902.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000008/wk-form4_1775681902.xml","form_type":"4"}},{"id":812634,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-08T20:58:25.000Z","date":"2026-04-07","kind":"sale","planned":true,"acquired":false,"shares":40000,"price":3.1,"value":124000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":906556,"source":{"system":"sec-edgar","filing":"0001856369-26-000008","document":"wk-form4_1775681902.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000008/wk-form4_1775681902.xml","form_type":"4"}},{"id":812633,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-08T20:58:25.000Z","date":"2026-04-07","kind":"exercise","planned":true,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":946556,"source":{"system":"sec-edgar","filing":"0001856369-26-000008","document":"wk-form4_1775681902.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000008/wk-form4_1775681902.xml","form_type":"4"}},{"id":812292,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":1009,"kind":"person","name":"Borgeson Blake","position":1,"cik":"0001856094","reported_name":"Borgeson Blake","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-08T20:58:18.000Z","date":"2026-04-07","kind":"sale","planned":true,"acquired":false,"shares":30000,"price":3.1,"value":93000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2025."}],"balance_after":6229863,"source":{"system":"sec-edgar","filing":"0001856094-26-000003","document":"wk-form4_1775681895.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000185609426000003/wk-form4_1775681895.xml","form_type":"4"}},{"id":819810,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":32942,"kind":"person","name":"Dar Zavain","position":1,"cik":"0001852075","reported_name":"Dar Zavain","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-02T20:56:26.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":4902,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":147231,"source":{"system":"sec-edgar","filing":"0001852075-26-000004","document":"wk-form4_1775163383.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852075/000185207526000004/wk-form4_1775163383.xml","form_type":"4"}},{"id":818912,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":10863,"kind":"person","name":"Li Dean Y","position":1,"cik":"0001837016","reported_name":"Li Dean Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-02T20:56:19.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":3268,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":1244177,"source":{"system":"sec-edgar","filing":"0001837016-26-000005","document":"wk-form4_1775163374.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000183701626000005/wk-form4_1775163374.xml","form_type":"4"}},{"id":828297,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2026-03-25T20:36:02.000Z","date":"2026-03-23","kind":"exercise","planned":true,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."}],"balance_after":4483334,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001601830-26-000052","document":"wk-form4_1774470960.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183026000052/wk-form4_1774470960.xml","form_type":"4"}},{"id":828296,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-25T20:36:02.000Z","date":"2026-03-23","kind":"sale","planned":true,"acquired":false,"shares":40000,"price":3.25,"value":130000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":906556,"source":{"system":"sec-edgar","filing":"0001601830-26-000052","document":"wk-form4_1774470960.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183026000052/wk-form4_1774470960.xml","form_type":"4"}},{"id":828295,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-25T20:36:02.000Z","date":"2026-03-23","kind":"exercise","planned":true,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":946556,"source":{"system":"sec-edgar","filing":"0001601830-26-000052","document":"wk-form4_1774470960.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183026000052/wk-form4_1774470960.xml","form_type":"4"}},{"id":834504,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-18T21:52:36.000Z","date":"2026-03-17","kind":"sale","planned":true,"acquired":false,"shares":7956,"price":3.39,"value":26970.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2025."}],"balance_after":1180318,"source":{"system":"sec-edgar","filing":"0001712276-26-000002","document":"wk-form4_1773870740.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000171227626000002/wk-form4_1773870740.xml","form_type":"4"}},{"id":834503,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-18T21:52:36.000Z","date":"2026-03-16","kind":"tax_withholding","planned":true,"acquired":false,"shares":7075,"price":3.42,"value":24196.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":1188274,"source":{"system":"sec-edgar","filing":"0001712276-26-000002","document":"wk-form4_1773870740.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000171227626000002/wk-form4_1773870740.xml","form_type":"4"}},{"id":848892,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2026-03-11T21:41:23.000Z","date":"2026-03-09","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."}],"balance_after":4523334,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001601830-26-000049","document":"wk-form4_1773265281.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183026000049/wk-form4_1773265281.xml","form_type":"4"}},{"id":848891,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-11T21:41:23.000Z","date":"2026-03-09","kind":"gift","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":906556,"source":{"system":"sec-edgar","filing":"0001601830-26-000049","document":"wk-form4_1773265281.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183026000049/wk-form4_1773265281.xml","form_type":"4"}},{"id":848890,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-11T21:41:23.000Z","date":"2026-03-09","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":926556,"source":{"system":"sec-edgar","filing":"0001601830-26-000049","document":"wk-form4_1773265281.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183026000049/wk-form4_1773265281.xml","form_type":"4"}},{"id":849092,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22356,"kind":"person","name":"Khan Najat","position":1,"cik":"0002020969","reported_name":"Khan Najat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Class A Common Stock","published_at":"2026-03-11T21:41:15.000Z","date":"2026-03-09","kind":"sale","planned":true,"acquired":false,"shares":28298,"price":3.3451,"value":94659.6398,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2025"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $3.32 to $3.405. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":2262085,"source":{"system":"sec-edgar","filing":"0001601830-26-000048","document":"wk-form4_1773265272.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2020969/000160183026000048/wk-form4_1773265272.xml","form_type":"4"}},{"id":860677,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":1009,"kind":"person","name":"Borgeson Blake","position":1,"cik":"0001856094","reported_name":"Borgeson Blake","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-04T21:38:45.000Z","date":"2026-03-03","kind":"sale","planned":true,"acquired":false,"shares":170000,"price":3.46,"value":588200.0,"ownership":{"direct":true},"balance_after":6259863,"source":{"system":"sec-edgar","filing":"0001601830-26-000045","document":"wk-form4_1772660322.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183026000045/wk-form4_1772660322.xml","form_type":"4"}},{"id":893690,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22339,"kind":"person","name":"Hallett David","position":1,"cik":"0002006495","reported_name":"Hallett David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-20T00:30:57.000Z","date":"2026-02-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":11908,"price":3.49,"value":41558.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":1097151,"source":{"system":"sec-edgar","filing":"0001601830-26-000022","document":"wk-form4_1771547454.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2006495/000160183026000022/wk-form4_1771547454.xml","form_type":"4"}},{"id":893584,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2026-02-20T00:30:51.000Z","date":"2026-02-19","kind":"exercise","planned":true,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."}],"balance_after":4543334,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001601830-26-000021","document":"wk-form4_1771547448.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183026000021/wk-form4_1771547448.xml","form_type":"4"}},{"id":893583,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-20T00:30:51.000Z","date":"2026-02-19","kind":"sale","planned":true,"acquired":false,"shares":40000,"price":3.46,"value":138400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":906556,"source":{"system":"sec-edgar","filing":"0001601830-26-000021","document":"wk-form4_1771547448.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183026000021/wk-form4_1771547448.xml","form_type":"4"}},{"id":893582,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-20T00:30:51.000Z","date":"2026-02-19","kind":"exercise","planned":true,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":946556,"source":{"system":"sec-edgar","filing":"0001601830-26-000021","document":"wk-form4_1771547448.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183026000021/wk-form4_1771547448.xml","form_type":"4"}},{"id":893581,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-20T00:30:51.000Z","date":"2026-02-17","kind":"tax_withholding","planned":true,"acquired":false,"shares":27265,"price":3.49,"value":95154.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":906556,"source":{"system":"sec-edgar","filing":"0001601830-26-000021","document":"wk-form4_1771547448.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183026000021/wk-form4_1771547448.xml","form_type":"4"}},{"id":892625,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-20T00:30:45.000Z","date":"2026-02-18","kind":"sale","planned":true,"acquired":false,"shares":13426,"price":3.08,"value":41352.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2025."}],"balance_after":1195349,"source":{"system":"sec-edgar","filing":"0001601830-26-000020","document":"wk-form4_1771547442.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183026000020/wk-form4_1771547442.xml","form_type":"4"}},{"id":892624,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-20T00:30:45.000Z","date":"2026-02-17","kind":"tax_withholding","planned":true,"acquired":false,"shares":11908,"price":3.49,"value":41558.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":1208775,"source":{"system":"sec-edgar","filing":"0001601830-26-000020","document":"wk-form4_1771547442.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183026000020/wk-form4_1771547442.xml","form_type":"4"}},{"id":893765,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22356,"kind":"person","name":"Khan Najat","position":1,"cik":"0002020969","reported_name":"Khan Najat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Class A Common Stock","published_at":"2026-02-20T00:30:39.000Z","date":"2026-02-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":14280,"price":3.49,"value":49837.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":2290383,"source":{"system":"sec-edgar","filing":"0001601830-26-000019","document":"wk-form4_1771547436.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2020969/000160183026000019/wk-form4_1771547436.xml","form_type":"4"}},{"id":912394,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22356,"kind":"person","name":"Khan Najat","position":1,"cik":"0002020969","reported_name":"Khan Najat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Class A Common Stock","published_at":"2026-02-10T23:18:29.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":10364,"price":3.98,"value":41248.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":2304663,"source":{"system":"sec-edgar","filing":"0001601830-26-000014","document":"wk-form4_1770765506.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2020969/000160183026000014/wk-form4_1770765506.xml","form_type":"4"}},{"id":912393,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22356,"kind":"person","name":"Khan Najat","position":1,"cik":"0002020969","reported_name":"Khan Najat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Class A Common Stock","published_at":"2026-02-10T23:18:29.000Z","date":"2026-02-06","kind":"grant","planned":false,"acquired":true,"shares":30346,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This RSU vested immediately upon the grant date."}],"balance_after":2315027,"source":{"system":"sec-edgar","filing":"0001601830-26-000014","document":"wk-form4_1770765506.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2020969/000160183026000014/wk-form4_1770765506.xml","form_type":"4"}},{"id":912392,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22356,"kind":"person","name":"Khan Najat","position":1,"cik":"0002020969","reported_name":"Khan Najat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Class A Common Stock","published_at":"2026-02-10T23:18:29.000Z","date":"2026-02-06","kind":"grant","planned":false,"acquired":true,"shares":1673546,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on May 15, 2026 and every three months thereafter."}],"balance_after":2284681,"source":{"system":"sec-edgar","filing":"0001601830-26-000014","document":"wk-form4_1770765506.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2020969/000160183026000014/wk-form4_1770765506.xml","form_type":"4"}},{"id":911384,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-10T23:18:20.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":11400,"price":3.98,"value":45372.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":1220683,"source":{"system":"sec-edgar","filing":"0001601830-26-000013","document":"wk-form4_1770765498.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183026000013/wk-form4_1770765498.xml","form_type":"4"}},{"id":911383,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-10T23:18:20.000Z","date":"2026-02-06","kind":"grant","planned":false,"acquired":true,"shares":24254,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This RSU vested immediately upon the grant date."}],"balance_after":1232083,"source":{"system":"sec-edgar","filing":"0001601830-26-000013","document":"wk-form4_1770765498.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183026000013/wk-form4_1770765498.xml","form_type":"4"}},{"id":911382,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-10T23:18:20.000Z","date":"2026-02-06","kind":"grant","planned":false,"acquired":true,"shares":446279,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on May 15, 2026 and every three months thereafter."}],"balance_after":1207829,"source":{"system":"sec-edgar","filing":"0001601830-26-000013","document":"wk-form4_1770765498.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183026000013/wk-form4_1770765498.xml","form_type":"4"}},{"id":912335,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22339,"kind":"person","name":"Hallett David","position":1,"cik":"0002006495","reported_name":"Hallett David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-10T23:18:12.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":11400,"price":3.98,"value":45372.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":1109059,"source":{"system":"sec-edgar","filing":"0001601830-26-000012","document":"wk-form4_1770765490.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2006495/000160183026000012/wk-form4_1770765490.xml","form_type":"4"}},{"id":912334,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22339,"kind":"person","name":"Hallett David","position":1,"cik":"0002006495","reported_name":"Hallett David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-10T23:18:12.000Z","date":"2026-02-06","kind":"grant","planned":false,"acquired":true,"shares":24254,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This RSU vested immediately upon the grant date."}],"balance_after":1120459,"source":{"system":"sec-edgar","filing":"0001601830-26-000012","document":"wk-form4_1770765490.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2006495/000160183026000012/wk-form4_1770765490.xml","form_type":"4"}},{"id":912333,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22339,"kind":"person","name":"Hallett David","position":1,"cik":"0002006495","reported_name":"Hallett David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-10T23:18:12.000Z","date":"2026-02-06","kind":"grant","planned":false,"acquired":true,"shares":502064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on May 15, 2026 and every three months thereafter."}],"balance_after":1096205,"source":{"system":"sec-edgar","filing":"0001601830-26-000012","document":"wk-form4_1770765490.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2006495/000160183026000012/wk-form4_1770765490.xml","form_type":"4"}},{"id":916116,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2026-02-06T22:53:41.000Z","date":"2026-02-04","kind":"exercise","planned":true,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."}],"balance_after":4583334,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001601830-26-000008","document":"wk-form4_1770418417.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183026000008/wk-form4_1770418417.xml","form_type":"4"}},{"id":916115,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-06T22:53:41.000Z","date":"2026-02-06","kind":"tax_withholding","planned":true,"acquired":false,"shares":10364,"price":3.56,"value":36895.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":933821,"source":{"system":"sec-edgar","filing":"0001601830-26-000008","document":"wk-form4_1770418417.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183026000008/wk-form4_1770418417.xml","form_type":"4"}},{"id":916114,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-06T22:53:41.000Z","date":"2026-02-06","kind":"grant","planned":true,"acquired":true,"shares":30346,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This RSU vested immediately upon the grant date."}],"balance_after":944185,"source":{"system":"sec-edgar","filing":"0001601830-26-000008","document":"wk-form4_1770418417.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183026000008/wk-form4_1770418417.xml","form_type":"4"}},{"id":916113,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-06T22:53:41.000Z","date":"2026-02-04","kind":"sale","planned":true,"acquired":false,"shares":40000,"price":4.12,"value":164800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":913839,"source":{"system":"sec-edgar","filing":"0001601830-26-000008","document":"wk-form4_1770418417.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183026000008/wk-form4_1770418417.xml","form_type":"4"}},{"id":916112,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-06T22:53:41.000Z","date":"2026-02-04","kind":"exercise","planned":true,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":953839,"source":{"system":"sec-edgar","filing":"0001601830-26-000008","document":"wk-form4_1770418417.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000160183026000008/wk-form4_1770418417.xml","form_type":"4"}},{"id":915731,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":1009,"kind":"person","name":"Borgeson Blake","position":1,"cik":"0001856094","reported_name":"Borgeson Blake","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-06T22:53:34.000Z","date":"2026-02-03","kind":"sale","planned":true,"acquired":false,"shares":220000,"price":4.2,"value":924000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2025."}],"balance_after":6429863,"source":{"system":"sec-edgar","filing":"0001601830-26-000007","document":"wk-form4_1770418411.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183026000007/wk-form4_1770418411.xml","form_type":"4"}},{"id":933477,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2026-01-23T00:34:42.000Z","date":"2026-01-20","kind":"exercise","planned":true,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."}],"balance_after":4623334,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001856369-26-000005","document":"wk-form4_1769128479.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000005/wk-form4_1769128479.xml","form_type":"4"}},{"id":933476,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-23T00:34:42.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":40000,"price":4.47,"value":178800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":913839,"source":{"system":"sec-edgar","filing":"0001856369-26-000005","document":"wk-form4_1769128479.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000005/wk-form4_1769128479.xml","form_type":"4"}},{"id":933475,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-23T00:34:42.000Z","date":"2026-01-20","kind":"exercise","planned":true,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":953839,"source":{"system":"sec-edgar","filing":"0001856369-26-000005","document":"wk-form4_1769128479.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000005/wk-form4_1769128479.xml","form_type":"4"}},{"id":942975,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":1009,"kind":"person","name":"Borgeson Blake","position":1,"cik":"0001856094","reported_name":"Borgeson Blake","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-08T22:01:40.000Z","date":"2026-01-06","kind":"sale","planned":true,"acquired":false,"shares":220000,"price":4.36,"value":959200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2025."}],"balance_after":6649863,"source":{"system":"sec-edgar","filing":"0001856094-26-000002","document":"wk-form4_1767909697.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000185609426000002/wk-form4_1767909697.xml","form_type":"4"}},{"id":944674,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2026-01-07T22:04:26.000Z","date":"2026-01-05","kind":"exercise","planned":true,"acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."}],"balance_after":4663334,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001856369-26-000003","document":"wk-form4_1767823462.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000003/wk-form4_1767823462.xml","form_type":"4"}},{"id":944673,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-07T22:04:26.000Z","date":"2026-01-05","kind":"gift","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":913839,"source":{"system":"sec-edgar","filing":"0001856369-26-000003","document":"wk-form4_1767823462.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000003/wk-form4_1767823462.xml","form_type":"4"}},{"id":944672,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-07T22:04:26.000Z","date":"2026-01-05","kind":"sale","planned":true,"acquired":false,"shares":40000,"price":4.25,"value":170000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":933839,"source":{"system":"sec-edgar","filing":"0001856369-26-000003","document":"wk-form4_1767823462.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000003/wk-form4_1767823462.xml","form_type":"4"}},{"id":944671,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-07T22:04:26.000Z","date":"2026-01-05","kind":"exercise","planned":true,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":973839,"source":{"system":"sec-edgar","filing":"0001856369-26-000003","document":"wk-form4_1767823462.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636926000003/wk-form4_1767823462.xml","form_type":"4"}},{"id":947008,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":32942,"kind":"person","name":"Dar Zavain","position":1,"cik":"0001852075","reported_name":"Dar Zavain","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-06T22:47:51.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":3571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":142329,"source":{"system":"sec-edgar","filing":"0001852075-26-000002","document":"wk-form4_1767739668.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852075/000185207526000002/wk-form4_1767739668.xml","form_type":"4"}},{"id":945695,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":10863,"kind":"person","name":"Li Dean Y","position":1,"cik":"0001837016","reported_name":"Li Dean Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-06T22:47:45.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":2381,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":1240909,"source":{"system":"sec-edgar","filing":"0001837016-26-000003","document":"wk-form4_1767739662.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000183701626000003/wk-form4_1767739662.xml","form_type":"4"}},{"id":956994,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22050,"kind":"person","name":"Taylor Ben R","position":1,"cik":"0001712276","reported_name":"Taylor Ben R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-12-31T00:35:12.000Z","date":"2025-12-29","kind":"sale","planned":true,"acquired":false,"shares":21383,"price":4.18,"value":89380.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2025."}],"balance_after":761550,"source":{"system":"sec-edgar","filing":"0001712276-25-000017","document":"wk-form4_1767141308.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000171227625000017/wk-form4_1767141308.xml","form_type":"4"}},{"id":958445,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22356,"kind":"person","name":"Khan Najat","position":1,"cik":"0002020969","reported_name":"Khan Najat","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2025-12-29T22:24:36.000Z","date":"2025-12-22","kind":"sale","planned":true,"acquired":false,"shares":124403,"price":4.4098,"value":548592.3494,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $4.30 to $4.48. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":611135,"source":{"system":"sec-edgar","filing":"0001601830-25-000176","document":"wk-form4_1767047073.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2020969/000160183025000176/wk-form4_1767047073.xml","form_type":"4"}},{"id":962120,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock","published_at":"2025-12-19T22:04:55.000Z","date":"2025-12-19","kind":"exercise","planned":true,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date."}],"balance_after":4723334,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001856369-25-000018","document":"wk-form4_1766181892.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636925000018/wk-form4_1766181892.xml","form_type":"4"}},{"id":962119,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":40978,"kind":"person","name":"Gibson Christopher","position":1,"cik":"0001856369","reported_name":"Gibson Christopher","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-12-19T22:04:55.000Z","date":"2025-12-19","kind":"sale","planned":true,"acquired":false,"shares":40000,"price":4.5,"value":180000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."}],"balance_after":913839,"source":{"system":"sec-edgar","filing":"0001856369-25-000018","document":"wk-form4_1766181892.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856369/000185636925000018/wk-form4_1766181892.xml","form_type":"4"}}],"next_cursor":"2025-12-19T22:04:55.000000Z,962119"}